259 related articles for article (PubMed ID: 24612427)
1. Management of orthopaedic surgery in rare bleeding disorders.
Siboni SM; Biguzzi E; Pasta G; Mannucci PM; Mistretta C; Fantini NN; Solimeno LP; Peyvandi F
Haemophilia; 2014 Sep; 20(5):693-701. PubMed ID: 24612427
[TBL] [Abstract][Full Text] [Related]
2. Orthopaedic surgery in patients with von Willebrand disease.
Siboni SM; Biguzzi E; Solimeno LP; Pasta G; Mistretta C; Mannucci PM; Peyvandi F
Haemophilia; 2014 Jan; 20(1):133-40. PubMed ID: 23992395
[TBL] [Abstract][Full Text] [Related]
3. Operative management and outcomes in children with congenital bleeding disorders: a retrospective review at a single haemophilia treatment centre.
Watts RG; Cook RP
Haemophilia; 2012 May; 18(3):421-5. PubMed ID: 21973059
[TBL] [Abstract][Full Text] [Related]
4. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
[TBL] [Abstract][Full Text] [Related]
5. Elective surgery in patients with congenital coagulopathies and inhibitors: experience of the National Haemophilia Centre of Venezuela.
Boadas A; Fernández-Palazzi F; De Bosch NB; Cedeño M; Ruiz-Sáez A
Haemophilia; 2011 May; 17(3):422-7. PubMed ID: 21118333
[TBL] [Abstract][Full Text] [Related]
6. Solvent/detergent plasma for prevention of bleeding in recessively inherited coagulation disorders: dosing, pharmacokinetics and clinical efficacy.
Santagostino E; Mancuso ME; Morfini M; Schiavoni M; Tagliaferri A; Barillari G; Mannucci PM
Haematologica; 2006 May; 91(5):634-9. PubMed ID: 16670069
[TBL] [Abstract][Full Text] [Related]
7. Major orthopaedic surgeries for haemophilia with inhibitors using rFVIIa.
Takedani H; Kawahara H; Kajiwara M
Haemophilia; 2010 Mar; 16(2):290-5. PubMed ID: 19925628
[TBL] [Abstract][Full Text] [Related]
8. Management of factor VII-deficient patients undergoing joint surgeries--preliminary results of locally developed treatment regimen.
Windyga J; Zbikowski P; Ambroziak P; Baran B; Kotela I; Stefanska-Windyga E
Haemophilia; 2013 Jan; 19(1):89-93. PubMed ID: 22845882
[TBL] [Abstract][Full Text] [Related]
9. Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency.
O'Connell NM; Riddell AF; Pascoe G; Perry DJ; Lee CA
Haemophilia; 2008 Jul; 14(4):775-81. PubMed ID: 18384352
[TBL] [Abstract][Full Text] [Related]
10. Prohemostatic treatment in cardiac surgery.
Levy JH; Sniecinski RM
Semin Thromb Hemost; 2012 Apr; 38(3):237-43. PubMed ID: 22510857
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Local Injection of Fresh Frozen Plasma to Traditional Methods of Hemostasis in Minimally Invasive Procedures.
Haaga J; Rahim S; Kondray V; Davidson J; Patel I; Nakamoto D
Acad Radiol; 2018 Dec; 25(12):1617-1623. PubMed ID: 29573937
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of plasma-derived coagulation factor IX concentrate (AlphaNine® SD) in patients with haemophilia B undergoing surgical intervention: a single institution retrospective analysis.
Quon DV; Logan L
Haemophilia; 2011 Jan; 17(1):e196-201. PubMed ID: 20618876
[TBL] [Abstract][Full Text] [Related]
13. Complications in oral and maxillofacial surgery: management of hemostasis and bleeding disorders in surgical procedures.
Malmquist JP
Oral Maxillofac Surg Clin North Am; 2011 Aug; 23(3):387-94. PubMed ID: 21658969
[TBL] [Abstract][Full Text] [Related]
14. Bleeding phenotype and correlation with factor XI (FXI) activity in congenital FXI deficiency: results of a retrospective study from a single centre.
Santoro C; Di Mauro R; Baldacci E; De Angelis F; Abbruzzese R; Barone F; Bochicchio RA; Ferrara G; Guarini A; Foà R; Mazzucconi MG
Haemophilia; 2015 Jul; 21(4):496-501. PubMed ID: 25623511
[TBL] [Abstract][Full Text] [Related]
15. Management of surgical hemostasis: systemic agents.
Levy JH; Tanaka KA
Vascular; 2008; 16 Suppl 1():S14-21. PubMed ID: 18544301
[TBL] [Abstract][Full Text] [Related]
16. Bleeding characteristics and management of minor surgeries in rare bleeding disorders: report from a Turkish Pediatric Hematology Center.
Gelen SA; Sarper N; Zengin E
Turk J Pediatr; 2020; 62(4):584-593. PubMed ID: 32779411
[TBL] [Abstract][Full Text] [Related]
17. Ongoing risk of thrombosis with factor XI concentrate: 5 years experience in two centres.
Batty P; Honke A; Bowles L; Hart DP; Pasi KJ; Uprichard J; Austin SK
Haemophilia; 2015 Jul; 21(4):490-5. PubMed ID: 25855341
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of a recombinant factor IX (Bax326) in previously treated patients with severe or moderately severe haemophilia B undergoing surgical or other invasive procedures: a prospective, open-label, uncontrolled, multicentre, phase III study.
Windyga J; Lissitchkov T; Stasyshyn O; Mamonov V; Ghandehari H; Chapman M; Fritsch S; Wong WY; Pavlova BG; Abbuehl BE
Haemophilia; 2014 Sep; 20(5):651-8. PubMed ID: 24697870
[TBL] [Abstract][Full Text] [Related]
19. Prohemostatic interventions in liver surgery.
Stellingwerff M; Brandsma A; Lisman T; Porte RJ
Semin Thromb Hemost; 2012 Apr; 38(3):244-9. PubMed ID: 22510858
[TBL] [Abstract][Full Text] [Related]
20. Tranexamic acid without prophylactic factor replacement for prevention of bleeding in hereditary bleeding disorder patients undergoing endoscopy: a pilot study.
Davis A; Walsh M; McCarthy P; Brown G; Roberts S; Tran H; Street A; Fong CY; Kemp W
Haemophilia; 2013 Jul; 19(4):583-9. PubMed ID: 23560720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
